In invasive breast carcinomas Nakopoulou et al [27] detected VEGFR-2 in 64.5% of cases but VEGFR-2 expression did not correlate with the stage of the disease or patients’ survival. This evidence concerns the gene KDR and invasive breast carcinoma.